| Year |
Citation |
Score |
| 2014 |
Casablanca Y, Mieznikowski J, Day R, Hamilton CA, Conrads TP, Maxwell GL, Hood BL, Wallace A, Rose GS, McMeekin DS. Molecular profiling of tumors from stage I versus stage III/IV cancer patients: A prediction signature for metastasis in Gynecologic Oncology Group 8024 Gynecologic Oncology. 133: 6. DOI: 10.1016/J.Ygyno.2014.03.031 |
0.353 |
|
| 2013 |
Risinger JI, Allard J, Chandran U, Day R, Chandramouli GV, Miller C, Zahn C, Oliver J, Litzi T, Marcus C, Dubil E, Byrd K, Cassablanca Y, Becich M, Berchuck A, et al. Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. Frontiers in Oncology. 3: 139. PMID 23785665 DOI: 10.3389/Fonc.2013.00139 |
0.325 |
|
| 2009 |
Wang M, Day R. Adaptive Bayesian design for phase I dose-finding trials using a joint model of response and toxicity. Journal of Biopharmaceutical Statistics. 20: 125-144. PMID 20077253 DOI: 10.1080/10543400903280613 |
0.303 |
|
| 2005 |
Ramanathan RK, Lee KM, McKolanis J, Hitbold E, Schraut W, Moser AJ, Warnick E, Whiteside T, Osborne J, Kim H, Day R, Troetschel M, Finn OJ. Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer. Cancer Immunology, Immunotherapy : Cii. 54: 254-64. PMID 15372205 DOI: 10.1007/S00262-004-0581-1 |
0.331 |
|
| 2004 |
Ramanathan RK, Hwang JJ, Zamboni WC, Sinicrope FA, Safran H, Wong MK, Earle M, Brufsky A, Evans T, Troetschel M, Walko C, Day R, Chen HX, Finkelstein S. Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trial. Cancer Investigation. 22: 858-65. PMID 15641483 DOI: 10.1081/Cnv-200039645 |
0.351 |
|
| 2004 |
Shackney SE, Smith CA, Pollice A, Brown K, Day R, Julian T, Silverman JF. Intracellular Patterns of Her-2/neu, ras, and Ploidy Abnormalities in Primary Human Breast Cancers Predict Postoperative Clinical Disease-Free Survival Clinical Cancer Research. 10: 3042-3052. PMID 15131041 DOI: 10.1158/1078-0432.Ccr-0401-3 |
0.346 |
|
| 2004 |
Welsh C, Day R, McGurk C, Masters JR, Wood RD, Köberle B. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. International Journal of Cancer. 110: 352-61. PMID 15095299 DOI: 10.1002/Ijc.20134 |
0.305 |
|
| 2004 |
Ramalingam S, Belani CP, Day R, Zamboni BA, Jacobs SA, Jett JR. Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 15: 247-51. PMID 14760117 DOI: 10.1093/Annonc/Mdh061 |
0.359 |
|
| 2001 |
Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL. The number of intratumoral dendritic cells and ζ-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma Cancer. 91: 2136-2147. PMID 11391595 DOI: 10.1002/1097-0142(20010601)91:11<2136::Aid-Cncr1242>3.0.Co;2-Q |
0.32 |
|
| 1997 |
Trump DL, Smith DC, Stiff D, Adedoyin A, Day R, Bahnson RR, Hofacker J, Branch RA. A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis. Cancer Chemotherapy and Pharmacology. 39: 349-56. PMID 9025776 DOI: 10.1007/S002800050582 |
0.303 |
|
| 1991 |
Vlock DR, Johnson J, Myers E, Day R, Gooding WE, Whiteside T, Pelch K, Sigler B, Wagner R, Colao D, Rust D. Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck. Head and Neck-Journal For the Sciences and Specialties of the Head and Neck. 13: 15-21. PMID 1989925 DOI: 10.1002/Hed.2880130103 |
0.34 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1995 |
Osborn JL, Schwartz GG, Smith DC, Bahnson R, Day R, Trump DL. Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urologic Oncology. 1: 195-8. PMID 21224117 DOI: 10.1016/1078-1439(95)00061-5 |
0.297 |
|
| 1995 |
Shannon WD, Bryant J, Logan TF, Day R. An application of decision theory to patient screening for an autologous tumour vaccine trial. Statistics in Medicine. 14: 2099-2110. PMID 8552889 DOI: 10.1002/Sim.4780141904 |
0.294 |
|
| 2013 |
Rodriguez GC, Barnes HJ, Anderson KE, Whitaker RS, Berchuck A, Petitte JN, Lancaster JM, Wenham RM, Turbov JM, Day R, Maxwell GL, Carver DK. Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying hen. Cancer Prevention Research (Philadelphia, Pa.). 6: 1283-92. PMID 24136864 DOI: 10.1158/1940-6207.Capr-12-0426 |
0.293 |
|
| 1998 |
Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. Journal of the National Cancer Institute. 90: 824-32. PMID 9625170 DOI: 10.1093/Jnci/90.11.824 |
0.29 |
|
| 1997 |
Faul CM, Mirmow D, Huang Q, Gerszten K, Day R, Jones MW. Adjuvant radiation for vulvar carcinoma : Improved local control International Journal of Radiation Oncology Biology Physics. 38: 381-389. PMID 9226327 DOI: 10.1016/S0360-3016(97)82500-X |
0.286 |
|
| 1995 |
Bryant J, Day R. Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics. 51: 1372-1383. DOI: 10.2307/2533268 |
0.283 |
|
| 1990 |
Md MSE, Md SGN, Md RRB, Miketic LM, Banner B, Gooding W, Day R, Whiteside T, Hakala T, Md JMK. A Phase IA Trial of Sequential Administration Recombinant DNA-Produced Interferons: Combination Recombinant Interferon Gamma and Recombinant Interferon Alfa in Patients with Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 8: 1637-1649. PMID 2120392 DOI: 10.1200/Jco.1990.8.10.1637 |
0.276 |
|
| 1990 |
Whiteside TL, Bryant J, Herberman RB, Day R. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. Journal of Clinical Laboratory Analysis. 4: 102-114. PMID 2179501 DOI: 10.1002/Jcla.1860040207 |
0.274 |
|
| 1992 |
Lotze PIMT, Rubin CJT, Edington HD, Posner MG, Wolmark N, Herberman iRB, Whiteside TL, Elder E, Dudjak L, Snyder J, Chelluri L, Hayes K, Kirkwood JM, Ernstoff M, Vlock DR, ... ... Day R, et al. The Treatment of Patients with Melanoma Using Interleukin-2, Interleukin-4 and Tumor Infiltrating Lymphocytes. University of Pittsburgh Human Gene Therapy. 3: 167-177. PMID 1391037 DOI: 10.1089/Hum.1992.3.2-167 |
0.269 |
|
| 1997 |
Day R, Bryant J, Lefkopoulou M. Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic indicators Biometrika. 84: 45-56. DOI: 10.1093/Biomet/84.1.45 |
0.267 |
|
| 1998 |
Pitman KT, Johnson JT, Edmgton H, Leon Barnes E, Day R, Wagner RL, Myers EN. Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck Archives of Otolaryngology - Head and Neck Surgery. 124: 790-793. PMID 9677115 DOI: 10.1001/Archotol.124.7.790 |
0.266 |
|
| 2011 |
Maxwell GL, Hood BL, Day R, Chandran U, Kirchner D, Kolli VS, Bateman NW, Allard J, Miller C, Sun M, Flint MS, Zahn C, Oliver J, Banerjee S, Litzi T, et al. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation. Gynecologic Oncology. 121: 586-94. PMID 21458040 DOI: 10.1016/J.Ygyno.2011.02.031 |
0.265 |
|
| 1992 |
Yin XY, Donovan-Peluso M, Whiteside TL, Johnson JT, Day R, Herberman RB, Locker J. Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck. Genes, Chromosomes & Cancer. 3: 443-54. PMID 1777414 DOI: 10.1002/Gcc.2870030606 |
0.254 |
|
| 2018 |
Morrison C, Pabla S, Conroy JM, Nesline MK, Glenn ST, Dressman D, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Lenzo FL, Omilian A, Bshara W, ... ... Day R, et al. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. Journal For Immunotherapy of Cancer. 6: 32. PMID 29743104 DOI: 10.1186/S40425-018-0344-8 |
0.247 |
|
| 1991 |
Bryant J, Day R. Empirical Bayes Analysis for Systems of Mixed Models with Linked Autocorrelated Random Effects Journal of the American Statistical Association. 86: 1007-1012. DOI: 10.1080/01621459.1991.10475145 |
0.243 |
|
| 1992 |
Bryant J, Day R, Whiteside TL, Herberman RB. Calculation of lytic units for the expression of cell-mediated cytotoxicity Journal of Immunological Methods. 146: 91-103. PMID 1735786 DOI: 10.1016/0022-1759(92)90052-U |
0.239 |
|
| 2007 |
Day R, Mohanty S, Bisceglia M, Acquafondata M, Dhir R, Becich M, Trump D, Nelson J. Randomized trial of toremifene to reduce high grade prostatic intraepithelial neoplasia (HGPIN) prior to radical prostatectomy (RP) Journal of Clinical Oncology. 25: 5150-5150. DOI: 10.1200/Jco.2007.25.18_Suppl.5150 |
0.236 |
|
| 1998 |
Adedoyin A, Stiff DD, Smith DC, Romkes M, Bahnson RC, Day R, Hofacker J, Branch RA, Trump DL. All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes. Cancer Chemotherapy and Pharmacology. 41: 133-9. PMID 9443626 DOI: 10.1007/S002800050719 |
0.225 |
|
| 2019 |
Conroy JM, Pabla S, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Wang Y, Lenzo FL, Bshara W, Khalil M, Dy GK, Madden KG, Shirai K, ... ... Day R, et al. Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. Journal For Immunotherapy of Cancer. 7: 18. PMID 30678715 DOI: 10.1186/S40425-018-0489-5 |
0.223 |
|
| 2010 |
Brenda D, Buch S, Nukui T, Day R, Siegfried J, Weissfeld J, Romkes M. Abstract LB-414: Variation in base excision repair genes and risk of smoking-related non-small cell lung cancer Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-414 |
0.223 |
|
| 1991 |
Furukawa H, Todo S, Imventarza O, Casavilla A, Wu YM, Scotti-Foglieni C, Broznick B, Bryant J, Day R, Starzl TE. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation. 51: 1000-1004. PMID 2031256 DOI: 10.1097/00007890-199105000-00013 |
0.216 |
|
| 2015 |
Day RS. What Tumor Dynamics Modeling Can Teach us About Exploiting the Stem-Cell View for Better Cancer Treatment. Cancer Informatics. 14: 25-36. PMID 25780337 DOI: 10.4137/CIN.S17294 |
0.203 |
|
| 1999 |
Hmelo C, Day R. Contextualized questioning to scaffold learning from simulations Computers & Education. 32: 151-164. DOI: 10.1016/S0360-1315(98)00062-1 |
0.195 |
|
| 2010 |
Day RS. Failsafe automation of Phase II clinical trial interim monitoring for stopping rules. Clinical Trials (London, England). 7: 78-84. PMID 20156959 DOI: 10.1177/1740774509355653 |
0.192 |
|
| 2010 |
Zeng X, Hood BL, Sun M, Conrads TP, Day RS, Weissfeld JL, Siegfried JM, Bigbee WL. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. Journal of Proteome Research. 9: 6440-9. PMID 20931982 DOI: 10.1021/Pr100696N |
0.166 |
|
| 2007 |
Day RS, Davis M. Clinical trial interim monitoring support: requirements and implementation. Amia ... Annual Symposium Proceedings / Amia Symposium. Amia Symposium. 926. PMID 18694026 |
0.156 |
|
| 2004 |
Day RS, Manning BK, Garrott D, Brufsky AM, Baar J, Egorin MJ, Shirey WE, Friedman C. Evaluation of the OncoTCap (Oncology Thinking Cap) simulation in teaching medical students about clinical trials: some successes and some surprises. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 19: 149-55. PMID 15458869 DOI: 10.1207/s15430154jce1903_8 |
0.155 |
|
| 2011 |
Zeng X, Hood BL, Zhao T, Conrads TP, Sun M, Gopalakrishnan V, Grover H, Day RS, Weissfeld JL, Wilson DO, Siegfried JM, Bigbee WL. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 725-34. PMID 21304412 DOI: 10.1097/Jto.0B013E31820C312E |
0.152 |
|
| 2010 |
Wang Y, Day R. An R package for simulation experiments evaluating clinical trial designs. Amia Joint Summits On Translational Science Proceedings Amia Summit On Translational Science. 2010: 61-5. PMID 21347151 |
0.13 |
|
| 2016 |
Day RS. Planning clinically relevant biomarker validation studies using the "number needed to treat" concept. Journal of Translational Medicine. 14: 117. PMID 27146704 DOI: 10.1186/s12967-016-0862-4 |
0.126 |
|
| 2015 |
Archer KJ, Dobbin K, Biswas S, Day RS, Wheeler DC, Wu H. Computer Simulation, Bioinformatics, and Statistical Analysis of Cancer Data and Processes. Cancer Informatics. 14: 247-51. PMID 26380548 DOI: 10.4137/Cin.S32525 |
0.125 |
|
| 2012 |
Buch SC, Diergaarde B, Nukui T, Day RS, Siegfried JM, Romkes M, Weissfeld JL. Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer. Molecular Carcinogenesis. 51: E11-20. PMID 21976407 DOI: 10.1002/Mc.20858 |
0.119 |
|
| 2002 |
Matin K, Egorin MJ, Ballesteros MF, Smith DC, Lembersky B, Day RS, Johnson CS, Trump DL. Phase I and pharmacokinetic study of vinblastine and high-dose megestrol acetate. Cancer Chemotherapy and Pharmacology. 50: 179-85. PMID 12203099 DOI: 10.1007/S00280-002-0484-9 |
0.103 |
|
| 2020 |
Tambo JA, Kansiime MK, Mugambi I, Rwomushana I, Kenis M, Day RK, Lamontagne-Godwin J. Understanding smallholders' responses to fall armyworm (Spodoptera frugiperda) invasion: Evidence from five African countries. The Science of the Total Environment. 740: 140015. PMID 32927537 DOI: 10.1016/j.scitotenv.2020.140015 |
0.086 |
|
| 2015 |
McDade KK, Chandran U, Day RS. Improving Cancer Gene Expression Data Quality through a TCGA Data-Driven Evaluation of Identifier Filtering. Cancer Informatics. 14: 149-61. PMID 26715829 DOI: 10.4137/CIN.S33076 |
0.085 |
|
| 2021 |
Maino JL, Schouten R, Overton K, Day R, Ekesi S, Bett B, Barton M, Gregg PC, Umina PA, Reynolds OL. Regional and seasonal activity predictions for fall armyworm in Australia. Current Research in Insect Science. 1: 100010. PMID 36003595 DOI: 10.1016/j.cris.2021.100010 |
0.084 |
|
| 2021 |
Early R, Rwomushana I, Chipabika G, Day R. Comparing, evaluating and combining statistical species distribution models and CLIMEX to forecast the distributions of emerging crop pests. Pest Management Science. PMID 34647405 DOI: 10.1002/ps.6677 |
0.081 |
|
| 2018 |
Jeger M, Bragard C, Caffier D, Candresse T, Chatzivassiliou E, Dehnen-Schmutz K, Gilioli G, Grégoire JC, Jaques Miret JA, Navarro MN, Niere B, Parnell S, Potting R, Rafoss T, ... ... Day R, et al. Pest risk assessment of for the European Union. Efsa Journal. European Food Safety Authority. 16: e05351. PMID 32626012 DOI: 10.2903/J.Efsa.2018.5351 |
0.079 |
|
| 2002 |
Rose C, Green M, Webber S, Kingsley L, Day R, Watkins S, Reyes J, Rowe D. Detection of Epstein-Barr Virus Genomes in Peripheral Blood B Cells from Solid-Organ Transplant Recipients by Fluorescence In Situ Hybridization Journal of Clinical Microbiology. 40: 2533-2544. PMID 12089275 DOI: 10.1128/Jcm.40.7.2533-2544.2002 |
0.077 |
|
| 2019 |
Agboyi LK, Mensah SA, Clottey VA, Beseh P, Glikpo R, Rwomushana I, Day R, Kenis M. Evidence of Leaf Consumption Rate Decrease in Fall Armyworm, , Larvae Parasitized by . Insects. 10. PMID 31744045 DOI: 10.3390/insects10110410 |
0.076 |
|
| 2013 |
Day RS, McDade KK. A decision theory paradigm for evaluating identifier mapping and filtering methods using data integration. Bmc Bioinformatics. 14: 223. PMID 23855655 DOI: 10.1186/1471-2105-14-223 |
0.074 |
|
| 2010 |
Wang J, Day R, Visweswaran S, Hogan W. The use of semantic distance metrics to support ontology audit. Amia ... Annual Symposium Proceedings / Amia Symposium. Amia Symposium. 2010: 842-6. PMID 21347097 |
0.07 |
|
| 2011 |
Day RS, McDade KK, Chandran UR, Lisovich A, Conrads TP, Hood BL, Kolli VS, Kirchner D, Litzi T, Maxwell GL. Identifier mapping performance for integrating transcriptomics and proteomics experimental results. Bmc Bioinformatics. 12: 213. PMID 21619611 DOI: 10.1186/1471-2105-12-213 |
0.067 |
|
| 2022 |
Senay SD, Pardey PG, Chai Y, Doughty L, Day R. Fall armyworm from a maize multi-peril pest risk perspective. Frontiers in Insect Science. 2: 971396. PMID 38468803 DOI: 10.3389/finsc.2022.971396 |
0.066 |
|
| 2006 |
Day RS. Challenges of biological realism and validation in simulation-based medical education. Artificial Intelligence in Medicine. 38: 47-66. PMID 16621481 DOI: 10.1016/j.artmed.2006.01.001 |
0.066 |
|
| 2013 |
Osmanbeyoglu HU, Lu KN, Oesterreich S, Day RS, Benos PV, Coronnello C, Lu X. Estrogen represses gene expression through reconfiguring chromatin structures. Nucleic Acids Research. 41: 8061-71. PMID 23821662 DOI: 10.1093/Nar/Gkt586 |
0.066 |
|
| 2008 |
Boak MB, M'ikanatha NM, Day RS, Harrison LH. Internet death notices as a novel source of mortality surveillance data. American Journal of Epidemiology. 167: 532-9. PMID 18079132 DOI: 10.1093/Aje/Kwm331 |
0.056 |
|
| 2007 |
Piwowar HA, Day RS, Fridsma DB. Sharing detailed research data is associated with increased citation rate. Plos One. 2: e308. PMID 17375194 DOI: 10.1371/journal.pone.0000308 |
0.054 |
|
| 2021 |
Agboyi LK, Layodé BFR, Fening KO, Beseh P, Clottey VA, Day R, Kenis M, Babendreier D. Assessing the Potential of Inoculative Field Releases of to Control in Ghana. Insects. 12. PMID 34442231 DOI: 10.3390/insects12080665 |
0.052 |
|
| 2022 |
Gómez-Undiano I, Musavi F, Mushobozi WL, David GM, Day R, Early R, Wilson K. Predicting potential global and future distributions of the African armyworm (Spodoptera exempta) using species distribution models. Scientific Reports. 12: 16234. PMID 36171335 DOI: 10.1038/s41598-022-19983-y |
0.051 |
|
| 2020 |
Constantine KL, Kansiime MK, Mugambi I, Nunda W, Chacha D, Rware H, Makale F, Mulema J, Lamontagne-Godwin J, Williams F, Edgington S, Day R. Why don't smallholder farmers in Kenya use more biopesticides? Pest Management Science. PMID 32400959 DOI: 10.1002/ps.5896 |
0.048 |
|
| 2022 |
Day R, Haggblade S, Moephuli S, Mwang'ombe A, Nouala S. Institutional and policy bottlenecks to IPM. Current Opinion in Insect Science. 52: 100946. PMID 35772691 DOI: 10.1016/j.cois.2022.100946 |
0.043 |
|
| 2022 |
Gómez-Undiano I, Musavi F, Mushobozi WL, David GM, Day R, Early R, Wilson K. Author Correction: Predicting potential global and future distributions of the African armyworm (Spodoptera exempta) using species distribution models. Scientific Reports. 12: 19883. PMID 36400836 DOI: 10.1038/s41598-022-24222-5 |
0.04 |
|
| 2020 |
Agboyi LK, Goergen G, Beseh P, Mensah SA, Clottey VA, Glikpo R, Buddie A, Cafà G, Offord L, Day R, Rwomushana I, Kenis M. Parasitoid Complex of Fall Armyworm, , in Ghana and Benin. Insects. 11. PMID 31973018 DOI: 10.3390/insects11020068 |
0.032 |
|
| 2019 |
Kansiime MK, Mugambi I, Rwomushana I, Nunda W, Lamontagne-Godwin J, Rware H, Phiri NA, Chipabika G, Ndlovu M, Day R. Farmer perception of fall armyworm (Spodoptera frugiderda J.E. Smith) and farm-level management practices in Zambia. Pest Management Science. PMID 31148397 DOI: 10.1002/ps.5504 |
0.03 |
|
| 2020 |
Giovani B, Blümel S, Lopian R, Teulon D, Bloem S, Galeano Martínez C, Beltrán Montoya C, Urias Morales CR, Dharmapuri S, Timote V, Horn N, Chouibani M, Mezui M'Ella JG, Herrera V, Castinel A, ... ... Day R, et al. Publisher Correction: Science diplomacy for plant health. Nature Plants. PMID 32989289 DOI: 10.1038/s41477-020-00794-w |
0.021 |
|
| 2020 |
Giovani B, Blümel S, Lopian R, Teulon D, Bloem S, Galeano Martínez C, Beltrán Montoya C, Urias Morales CR, Dharmapuri S, Timote V, Horn N, Chouibani M, Mezui M'Ella JG, Herrera V, Castinel A, ... ... Day R, et al. Science diplomacy for plant health. Nature Plants. 6: 902-905. PMID 32782407 DOI: 10.1038/s41477-020-0744-x |
0.01 |
|
| 2016 |
Day RS. Want a letter? You write it for me. Science (New York, N.Y.). 351: 198. PMID 26744407 DOI: 10.1126/science.351.6269.198 |
0.01 |
|
| Hide low-probability matches. |